Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2015, Article ID 437271, 4 pages
http://dx.doi.org/10.1155/2015/437271
Research Article

Decreased Perifoveal Sensitivity Detected by Microperimetry in Patients Using Hydroxychloroquine and without Visual Field and Fundoscopic Anomalies

1Clínica Optométrica, Fundació Lluis Alcanyis, Universitat de Valencia, Calle de la Guardia Civil 22, 46020 Valencia, Spain
2Oftalmar, Hospital Internacional Medimar, Edificio de Especialidades, 03016 Alicante, Spain
3Departamento de Óptica, Anatomía y Farmacología, Universidad de Alicante, Carretera de San Vicente del Raspeig s/n, 03690 Alicante, Spain

Received 19 January 2015; Accepted 6 March 2015

Academic Editor: Stephen Charn Beng Teoh

Copyright © 2015 A. Molina-Martín et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. M. Santaella and F. W. Fraunfelder, “Ocular adverse effects associated with systemic medications: recognition and management,” Drugs, vol. 67, no. 1, pp. 75–93, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. R. V. Shearer and E. L. Dubois, “Ocular changes induced by long-term hydroxychloroquine (Plaquenil) therapy,” American Journal of Ophthalmology, vol. 64, no. 2, pp. 245–252, 1967. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Mißner and U. Kellner, “Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 250, no. 3, pp. 319–325, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. A. E. Semmer, M. S. Lee, A. R. Harrison, and T. W. Olsen, “Hydroxychloroquine retinopathy screening,” British Journal of Ophthalmology, vol. 92, no. 12, pp. 1653–1655, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Rohrschneider, S. Bültmann, and C. Springer, “Use of fundus perimetry (microperimetry) to quantify macular sensitivity,” Progress in Retinal and Eye Research, vol. 27, no. 5, pp. 536–548, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. J. C. S. Yam and A. K. H. Kwok, “Ocular toxicity of hydroxychloroquine,” Hong Kong Medical Journal, vol. 12, no. 4, pp. 294–304, 2006. View at Google Scholar · View at Scopus
  7. J. A. Rodriguez-Padilla, T. R. Hedges III, B. Monson et al., “High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy,” Archives of Ophthalmology, vol. 125, no. 6, pp. 775–780, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Frederick and M. F. Marmor, “Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus,” Arthritis Care and Research, vol. 62, no. 6, pp. 775–784, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. F. Marmor, R. E. Carr, M. Easterbrook, A. A. Farjo, W. F. Mieler, and American Academy of Ophthalmology, “Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology,” Ophthalmology, vol. 109, no. 7, pp. 1377–1382, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. M. F. Marmor, U. Kellner, T. Y. Y. Lai, J. S. Lyons, and W. F. Mieler, “Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy,” Ophthalmology, vol. 118, no. 2, pp. 415–422, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Rüther, J. Foerster, S. Berndt, and J. Schroeter, “Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses,” Ophthalmologe, vol. 104, no. 10, pp. 875–880, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Michaelides, N. B. Stover, P. J. Francis, and R. G. Weleber, “Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy,” Archives of Ophthalmology, vol. 129, no. 1, pp. 30–39, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Salu, A. Uvijls, P. van den Brande, and B. P. Leroy, “Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up,” Documenta Ophthalmologica, vol. 120, no. 3, pp. 251–264, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Bergholz, J. Schroeter, and K. Rüther, “Evaluation of risk factors for retinal damage due to chloroquine and hydroxychloroquine,” British Journal of Ophthalmology, vol. 94, no. 12, pp. 1637–1642, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Tehrani, R. A. Ostrowski, R. Hariman, and W. M. Jay, “Ocular toxicity of hydroxychloroquine,” Seminars in Ophthalmology, vol. 23, no. 3, pp. 201–209, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. F. Marmor, “Fundus autofluorescence is not the best early screen for hydroxychloroquine toxicity,” JAMA Ophthalmology, vol. 131, no. 11, pp. 1487–1488, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. D. F. Farrell, “Retinal toxicity to antimalarial drugs: chloroquine and hydroxychloroquine: a neurophysiologic study,” Clinical Ophthalmology, vol. 6, no. 1, pp. 377–383, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Angi, V. Romano, X. Valldeperas, F. Romano, and M. R. Romano, “Macular sensitivity changes for detection of chloroquine toxicity in asymptomatic patient,” International Ophthalmology, vol. 30, no. 2, pp. 195–197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Martínez-Costa, M. Victoria Ibañez, C. Murcia-Bello et al., “Use of microperimetry to evaluate hydroxychloroquine and chloroquine retinal toxicity,” Canadian Journal of Ophthalmology, vol. 48, no. 5, pp. 400–405, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. R. V. Jivrajka, M. A. Genead, J. J. Mcanany, C. C. Chow, and W. F. Mieler, “Microperimetric sensitivity in patients on hydroxychloroquine (Plaquenil) therapy,” Eye, vol. 27, no. 9, pp. 1044–1052, 2013. View at Publisher · View at Google Scholar · View at Scopus